A61K51/12 - CPC Classification Index

ClassID:

21597 ⎘

A61K51/12 - CPC Classification

Classification description:

Preparations containing radioactive substances for use in therapy or testing characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules

Sub-classes:

A61K51/1203 » {in a form not provided for by groups to , e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors} 86
A61K51/1206 » {Administration of radioactive gases, aerosols or breath tests} 46
A61K51/121 » {Solutions, i.e. homogeneous liquid formulation} 78
A61K51/1213 » {Semi-solid forms, gels, hydrogels, ointments, fats and waxes that are solid at room temperature} 81
A61K51/1217 » {Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols} 61
A61K51/1241 » {particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins} 34
A61K51/1258 » {Pills, tablets, lozenges} 4
A61K51/1262 » {Capsules} 5
A61K51/1268 » {host-guest, closed hollow molecules, inclusion complexes, e.g. with cyclodextrins, clathrates, cavitates, fullerenes} 25
A61K51/1272 » {Sponges} 1
A61K51/1275 » {Fibers, textiles, slabbs, or sheets} 7
A61K51/1279 » {Plasters, bandages, dressings, patches or adhesives} 14
A61K51/1282 » {Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents} 152
A61K51/1293 » {Radioactive cosmetics, e.g. radioactive bathsalts, soaps} 0
A61K51/1296 » {Radioactive food, e.g. chocolates, drinks} 8

Recent Application in this class:

20250090700

2025-03-20

HUMANIZED ANTIBODY THAT BINDS TO HEG1 PROTEIN AND COMPLEX OF ANTIBODY AND RADIONUCLIDE

20240199722

2024-06-20

NANOPLATFORM FOR TARGETING MACROPHAGE AND COMPOSITION FOR PREVENTION OR TREATMENT OF METASTATIC CANCER

20220273832

2022-09-01

RADIOLABELED LIPOSOMES AND METHODS OF USE THEREOF

20220047728

2022-02-17

RNA nanoparticles and method of use thereof

20200254120

2020-08-13

Organ protection in PSMA-targeted radionuclide therapy of prostate cancer

20200054894

2020-02-20

Patch with active ingredients

20190322723

2019-10-24

Peptide-Mediated Non-Covalent Delivery of Active Agents Across the Blood-Brain Barrier

20190257904

2019-08-22

Systems and methods for polarized nuclear imaging and spectroscopy

20190002544

2019-01-03

Blood-brain barrier permeable peptide compositions comprising a VAB domain of an anti-amyloid-beta camelid single-domain heavy-chain only antibody

#10

20180308600

2018-10-25

Method and apparatus for the production of lead 212 for medical use

#11

20180230432

2018-08-16

MEANS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISEASES

#12

20180207299

2018-07-26

Organ protection in PSMA-targeted radionuclide therapy of prostate cancer

#13

20180092997

2018-04-05

RNA nanoparticles and method of use thereof

#14

20170296680

2017-10-19

Anti-tau antibody and uses thereof

#15

20170145076

2017-05-25

Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier

#16

20160207020

2016-07-21

Reversible microcapsule filter cake

#17

20160106866

2016-04-21

Tripartite cancer theranostic nucleic acid constructs

#18

20160067361

2016-03-10

Organ protection in PSMA-targeted radionuclide therapy of prostate cancer

#19

20150374883

2015-12-31

Bone graft substitute containing a temporary contrast agent and a method of generating such and a method of use thereof

#20

20150170776

2015-06-18

Method and apparatus for the production of lead 212 for medical use

#21

20150110713

2015-04-23

METHOD AND COMPOSITION FOR TREATING CANCER

#22

20140363482

2014-12-11

Bioerodible sustained release drug delivery systems

#23

20140328866

2014-11-06

Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier

#24

20130251630

2013-09-26

Entrapment of radionuclides in nanoparticle compositions

#25

20120128783

2012-05-24

Compositions and methods for delivery of frozen particle adhesives

#26

20120107243

2012-05-03

PEPTIDE-MEDIATED NON-COVALENT DELIVERY OF ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER

#27

20120065365

2012-03-15

Stable Radiopharmaceutical Compositions and Methods for Their Preparation

#28

20110206606

2011-08-25

STABLE RADIOPHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREPARATION

#29

20110105892

2011-05-05

Physiological pharmacokinetic analysis for combined molecular MRI and dynamic PET imaging

#30

20100160711

2010-06-24

Fillers and methods for displacing tissues to improve radiological outcomes

#31

20100150830

2010-06-17

METHOD OF TREATING CANCER

#32

20100113614

2010-05-06

Compositions and methods for delivery of frozen particle adhesives

#33

20100112093

2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#34

20100111857

2010-05-06

Compositions and methods for surface abrasion with frozen particles

#35

20100111848

2010-05-06

Compositions and methods for administering compartmentalized frozen particles

#36

20100111847

2010-05-06

Compositions and methods for administering compartmentalized frozen particles

#37

20100111846

2010-05-06

Compositions and methods for delivery of frozen particle adhesives

#38

20100111845

2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#39

20100111841

2010-05-06

Compositions and methods for surface abrasion with frozen particles

#40

20100111836

2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#41

20100111835

2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#42

20100111834

2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#43

20100111833

2010-05-06

Compositions and methods for surface abrasion with frozen particles

#44

20100111832

2010-05-06

Compositions and methods for surface abrasion with frozen particles

#45

20100104467

2010-04-29

Production of thorium 228 starting from a natural thorium salt

#46

20080274048

2008-11-06

Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications

#47

20070269375

2007-11-22

Stable Radiopharmaceutical Compositions and Methods for Preparation

#48

20070189965

2007-08-16

Copper-complex isonitrile positron emission tomography (pet) imaging agent and method

#49

20070086944

2007-04-19

Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications

#50

20060216230

2006-09-28

Radioactive bone cement for treatment of tumors in bone

#51

20060153771

2006-07-13

Preparations for measuring gastric emptying ability

#52

20050180918

2005-08-18

Stabilization of radiopharmaceutical compositions using hydrophilic thioethers

#53

20050171023

2005-08-04

Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents

#54

20050063904

2005-03-24

Method for continuous visualization of a blood clot or plaque in body lumen

#55

20050025834

2005-02-03

Bioerodible sustained release drug delivery systems